Connection

Andrew Pollard to Respiratory Syncytial Virus, Human

Back to Details
This is a "connection" page, showing publications Andrew Pollard has written about Respiratory Syncytial Virus, Human.
Andrew Pollard
Connection Strength
1.028
Respiratory Syncytial Virus, Human
  1. Airway response to respiratory syncytial virus has incidental antibacterial effects. Nat Commun. 2019 05 17; 10(1):2218.
    View in: PubMed
    Score: 0.463
  2. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults. J Infect. 2019 05; 78(5):382-392.
    View in: PubMed
    Score: 0.454
  3. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection. Vaccine. 2018 11 12; 36(46):6988-6994.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.